Pinned Tweet
Join me and many other scientists on BlueSky. It is really nice there!
You can find me @mardakheh.bsky.social
bsky.app/profile/mardakheh.b…
Faraz K Mardakheh retweeted
Happy to share our new work with @haognguyen on targeting mRNA translation of oncogenes by RNA structure remodeling with a small molecule zotatifin. Congrats to @DuyguKuzuoglu an amazing postdoc and all the authors and collaborators!
cell.com/cancer-cell/fulltex…
Our post is now live! Apply and join us!
my.corehr.com/pls/uoxrecruit…
I don’t post here much anymore, but this one is an important announcement for us: 🚨We are Recruiting! So come join us! 🚨#RNA #CancerResearch
Faraz K Mardakheh retweeted
[3/5]
Faraz Mardakheh received a Programme Foundation Award to uncover the mechanisms behind malignant dysregulation of ribosome biogenesis & its impact on tumorigenesis to identify novel cancer-specific therapeutic targets.
@FKHM | @QMUL | @UniofOxford | #CRUKFunded
Faraz K Mardakheh retweeted
We are looking to recruit a highly motivated postdoc with cell or molecular biology expertise. Excellent #epigenetics, #chromatin training & networking opportunities @qmulepigenetics
DM me for inquiries pl apply/share tinyurl.com/m6jnksk5
Faraz K Mardakheh retweeted
The Barr lab @BiochemOxford has discovered the important role of cell division timing mechanisms in the formation of cancer. The research, funded by Cancer Research UK, provides valuable insight into how damaged cells are normally stopped from growing. ⬇️bit.ly/202502-barr
I don’t post here much anymore, but this one is an important announcement for us: 🚨We are Recruiting! So come join us! 🚨#RNA #CancerResearch
Faraz K Mardakheh retweeted
Our latest from the indefatigable @iamjohnnyyu in collaboration with @JswLab and @kevansf. Meet GENEVA, which enables simultaneous phenotyping and profiling of cancer cell drug responses at scale; both in vitro and in vivo across a variety of models: biorxiv.org/content/10.1101/…
Faraz K Mardakheh retweeted
Our Unit Director Prof Anne Willis has been awarded the prestigious John Barnes Prize Award from the British Toxicology Society. This prize was established in memory of the pioneering toxicologist and first Unit Director, Dr John Barnes. See more here: buff.ly/3D3BJoZ
Faraz K Mardakheh retweeted
Replying to @iamjohnnyyu
@iamjohnnyyu, @nalidoust, @kevansf, and I are excited to announce a historic achievement by our team at @vevo_ai: Tahoe-100M, a 100M single-cell transcriptomic atlas, measuring how thousands of drugs impact cells from 50 diverse cancer lines.
prnewswire.com/news-releases…
Faraz K Mardakheh retweeted
Exciting study by Amanda Andersson Rolf et al: In vitro expansion of a human fetal #pancreas #stemcell that generates all three pancreatic cell lineages”. cell.com/cell/fulltext/S0092… 1/
Faraz K Mardakheh retweeted
Looking for #mechanobiology enthusiasts for an exciting new project - apply and spread the word! 🤩
We are looking for a: POSTDOC (M/F/D)
Interested in implementing cutting-edge technologies, developing new tools, and their integration with spatial transcriptomics and mechanical measurements? Then apply 'til Dec. 31, 2024!
jobs.mpi-muenster.mpg.de/job…
Faraz K Mardakheh retweeted
Excited to share our latest work published in collaboration with Huakun Zhang’s group on how RNA structure regulates subgenomic RNA decay in wheat @BRiC_ISP @JohnInnesCentre @HaopengYu nature.com/articles/s41467-0…
Faraz K Mardakheh retweeted
Promising new treatment approach for severe COVID-19! Clinical trial with Fas ligand blocker shows faster recovery & reduced mortality. Approach targets immune overreaction, potentially effective against future viruses too. #COVID19 #Science #PublicHealth
t.ly/6kalU
Faraz K Mardakheh retweeted
It's our great pleasure to share our work on the role of CADASIL NOTCH3 mutations in the development of DNMT3A-related Clonal Hematopoiesis. Published now in @LeukemiaJnl
Huge congrats to Raúl Sánchez-Lanzas!!!
Many thanks to @LeukUK @The_MRC
nature.com/articles/s41375-0…
Faraz K Mardakheh retweeted
Hi Science friends and followers - its time to move to Bluesky.
Over the past 2 weeks the number of my followers has doubled from ~200 to ~400 with alsmot all of them scientists.
We have starter packs (designated lists of who to follow e.g. by research fields).




















